TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 334 filers reported holding TANDEM DIABETES CARE INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $871,530 | -16.9% | 41,961 | -1.8% | 0.04% | -10.4% |
Q2 2023 | $1,048,840 | +1.6% | 42,740 | +68.2% | 0.05% | -4.0% |
Q1 2023 | $1,032,063 | -21.2% | 25,414 | -12.7% | 0.05% | -25.4% |
Q4 2022 | $1,309,124 | +1.6% | 29,124 | +8.2% | 0.07% | -5.6% |
Q3 2022 | $1,288,000 | -3.5% | 26,909 | +19.3% | 0.07% | +1.4% |
Q2 2022 | $1,335,000 | -46.4% | 22,550 | +5.3% | 0.07% | -34.0% |
Q1 2022 | $2,492,000 | -16.4% | 21,424 | +8.2% | 0.11% | -8.6% |
Q4 2021 | $2,981,000 | +37.3% | 19,802 | +8.9% | 0.12% | +28.9% |
Q3 2021 | $2,171,000 | +52.5% | 18,184 | +24.4% | 0.09% | +55.2% |
Q2 2021 | $1,424,000 | +25.1% | 14,616 | +13.4% | 0.06% | +16.0% |
Q1 2021 | $1,138,000 | +26.4% | 12,891 | +37.1% | 0.05% | +19.0% |
Q4 2020 | $900,000 | +25.7% | 9,404 | +49.0% | 0.04% | +13.5% |
Q3 2020 | $716,000 | +22.6% | 6,312 | +6.9% | 0.04% | +12.1% |
Q2 2020 | $584,000 | +106.4% | 5,905 | +34.3% | 0.03% | +65.0% |
Q1 2020 | $283,000 | – | 4,396 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 1,022,257 | $60,293,000 | 5.97% |
APIS CAPITAL ADVISORS, LLC | 50,000 | $2,949,000 | 4.62% |
SECTORAL ASSET MANAGEMENT INC | 432,815 | $25,527,000 | 4.40% |
CROWN ADVISORS MANAGEMENT, INC. | 75,000 | $4,424,000 | 2.96% |
OBERWEIS ASSET MANAGEMENT INC/ | 199,410 | $11,761,000 | 2.66% |
Asymmetry Capital Management, L.P. | 18,995 | $1,120,000 | 2.40% |
Redmile Group, LLC | 1,160,401 | $68,440,000 | 2.29% |
FRIESS ASSOCIATES LLC | 501,985 | $29,607,000 | 2.29% |
Atika Capital Management LLC | 142,000 | $8,375,000 | 1.76% |
Chicago Capital, LLC | 433,083 | $25,543,000 | 1.71% |